1. Home
  2. AGIO vs ABM Comparison

AGIO vs ABM Comparison

Compare AGIO & ABM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGIO
  • ABM
  • Stock Information
  • Founded
  • AGIO 2007
  • ABM 1909
  • Country
  • AGIO United States
  • ABM United States
  • Employees
  • AGIO N/A
  • ABM N/A
  • Industry
  • AGIO Biotechnology: Pharmaceutical Preparations
  • ABM Diversified Commercial Services
  • Sector
  • AGIO Health Care
  • ABM Finance
  • Exchange
  • AGIO Nasdaq
  • ABM Nasdaq
  • Market Cap
  • AGIO 3.0B
  • ABM 3.6B
  • IPO Year
  • AGIO 2013
  • ABM N/A
  • Fundamental
  • Price
  • AGIO $55.68
  • ABM $56.82
  • Analyst Decision
  • AGIO Buy
  • ABM Hold
  • Analyst Count
  • AGIO 7
  • ABM 3
  • Target Price
  • AGIO $52.33
  • ABM $55.33
  • AVG Volume (30 Days)
  • AGIO 740.7K
  • ABM 311.9K
  • Earning Date
  • AGIO 10-31-2024
  • ABM 12-11-2024
  • Dividend Yield
  • AGIO N/A
  • ABM 1.58%
  • EPS Growth
  • AGIO N/A
  • ABM N/A
  • EPS
  • AGIO 11.80
  • ABM 2.43
  • Revenue
  • AGIO $32,871,000.00
  • ABM $8,274,900,000.00
  • Revenue This Year
  • AGIO $33.38
  • ABM $3.00
  • Revenue Next Year
  • AGIO $163.06
  • ABM $1.31
  • P/E Ratio
  • AGIO $4.72
  • ABM $23.38
  • Revenue Growth
  • AGIO 36.79
  • ABM 3.25
  • 52 Week Low
  • AGIO $20.96
  • ABM $39.64
  • 52 Week High
  • AGIO $62.58
  • ABM $59.78
  • Technical
  • Relative Strength Index (RSI)
  • AGIO 62.44
  • ABM 59.97
  • Support Level
  • AGIO $52.09
  • ABM $54.42
  • Resistance Level
  • AGIO $62.58
  • ABM $59.15
  • Average True Range (ATR)
  • AGIO 2.91
  • ABM 1.19
  • MACD
  • AGIO -0.11
  • ABM -0.07
  • Stochastic Oscillator
  • AGIO 64.30
  • ABM 58.02

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

About ABM ABM Industries Incorporated

ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.

Share on Social Networks: